Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Daniel Rubin, PhD

FDA

Disclosure(s): No financial relationships to disclose

Poster(s):

223 - Development and Analysis of a Novel DOOR Endpoint for Complicated Intra-abdominal Infections (cIAI) Using 10 Registrational Trials for Antibacterial Drugs
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET